IHH Annual Report 2024

37 Investors and shareholders We build trust with our investors and shareholders by prioritising transparent communication, providing regular financial updates and corporate developments, while fostering long-term, meaningful relationships. Local communities and the public IHH Cares. For Good. by continually expanding our reach to local populations in the markets we operate in, contributing to the improvement of global health. Our planet As a global healthcare operator, we believe that driving business growth must go hand in hand with environmental stewardship. We are committed to achieving net-zero emissions by 2050. Rooftop solar currently installed in Gleneagles Hong Kong and 10 hospitals in MY, with 6 more planned for 2025. Invested in large scale solar project in Acibadem, which is expected to operationalise in 2025, supplying up to 80% of Acıbadem’s energy needs in Türkiye 946 patients in Malaysia received free cancer treatment through Life Renewed programme since 2023 Conducted >3.1 million health screenings and cancer screenings for breast, cervical and colorectal cancers since 2022 10 awards won 459 investor meetings held 15 conferences and non-deal roadshows attended At 9% based on FY2024 Return on Equity (incl MFRS 129) Total dividend 10.0 sen declared for FY2024, comprising interim cash dividend of 4.5 sen and a final cash dividend of 5.5 sen See page 107 on Investor Relations for more information. >90% reduction in single-use virgin plastics in non-clinical areas across Malaysia, Türkiye, Singapore and Hong Kong

RkJQdWJsaXNoZXIy NDgzMzc=